English Polski
Tom 12, Nr 4 (2017)
Medycyna oparta na faktach – co nowego?
Opublikowany online: 2017-09-19

dostęp otwarty

Wyświetlenia strony 538
Wyświetlenia/pobrania artykułu 1141
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Najnowsze doniesienia kardiologiczne znad Potomaku — relacja z kongresu American College of Cardiology Waszyngton, 17–19 marca 2017

Aleksandra M. Mamzer-Dachnowska, Jarosław D. Kasprzak
Folia Cardiologica 2017;12(4):431-435.

Streszczenie

Brak

Referencje

  1. Reardon MJ, Van Mieghem NM, Popma JJ, et al. SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017; 376(14): 1321–1331.
  2. Chakravarty T, Søndergaard L, Friedman J, et al. RESOLVE, SAVORY Investigators. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017; 389(10087): 2383–2392.
  3. Ohman EM, Roe MT, Steg PG, et al. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet. 2017; 389(10081): 1799–1808.
  4. Smits PC, Abdel-Wahab M, Neumann FJ, et al. Compare-Acute Investigators. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017; 376(13): 1234–1244.
  5. Davies JE, Sen S, Dehbi HM. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med. 2017; 376(19): 1824–1834.
  6. Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. iFR-SWEDEHEART Investigators. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med. 2017; 376(19): 1813–1823.
  7. Park SJ, et al. Optimal medical therapy with or without stenting for coronary chronic total occlusion — DECISION-CTO. American College of Cardiology Annual Scientific Session (ACC 2017), Washington, DC, March 18, 2017.
  8. Ellis S, Kereiakes DJ, et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting Stent III — ABSORB III. American College of Cardiology Annual Scientific Session (ACC 2017), Washington, DC, March 18, 2017.
  9. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017; 70(2): 252–289.